Back
Northrop Grumman Vs. Summit Therapeutics Industry Stock Comparison
Buy
56
NOC
Northrop Grumman
Last Price:
$482.38
Seasonality Move:
6.19%
Sell
48
SMMT
Summit Therapeutics
Last Price:
$19.03
Seasonality Move:
17.04%
Buy
56
Northrop Grumman (NOC)
is a Buy
Is Northrop Grumman a Buy, Sell or Hold?
-
The current Northrop Grumman [NOC] share price is $482.38. The Score for NOC is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
-
NOC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
48
Summit Therapeutics (SMMT)
is a Sell
Is Summit Therapeutics a Buy, Sell or Hold?
-
The current Summit Therapeutics [SMMT] share price is $19.03. The Score for SMMT is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
SMMT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NOC Stock Price Chart
What is Northrop Grumman's stock price today?
-
The Northrop Grumman share price today is $482.38Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NOC is experiencing buying pressure, which is a positive indicator for future bullish movement.
SMMT Stock Price Chart
What is Summit Therapeutics's stock price today?
-
The Summit Therapeutics share price today is $19.03Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SMMT is experiencing slight buying pressure.
NOC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.06 | Sell |
Relative Strength Index (14 RSI): | 56.66 | Buy |
Chaikin Money Flow: | 713705 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (462.79 - 478.81) | Buy |
Bollinger Bands (100): | (479.17 - 528.07) | Sell |
SMMT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.11 | Sell |
Relative Strength Index (14 RSI): | 54.1 | Buy |
Chaikin Money Flow: | 834162 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (17.6 - 18.8) | Buy |
Bollinger Bands (100): | (16.03 - 22.61) | Sell |
NOC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 469.63 | Buy |
20-day SMA: | 468.5 | Buy |
50-day SMA: | 484.44 | Sell |
200-day SMA: | 482.24 | Buy |
8-day EMA: | 473.49 | Buy |
20-day EMA: | 472.29 | Buy |
50-day EMA: | 481.92 | Buy |
200-day EMA: | 484.38 | Sell |
SMMT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 18.13 | Buy |
20-day SMA: | 18.16 | Buy |
50-day SMA: | 18.72 | Buy |
200-day SMA: | 13.25 | Buy |
8-day EMA: | 18.21 | Buy |
20-day EMA: | 18.22 | Buy |
50-day EMA: | 18.47 | Buy |
200-day EMA: | 14.37 | Buy |
Northrop Grumman Earnings Growth & NOC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.89 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.04 per share, and an increase next year of $1.78 per share.
Summit Therapeutics Earnings Growth & SMMT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.08 per share, and a decrease next year of $0.16 per share.
Northrop Grumman Technical Analysis
Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
03 | 06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Summit Therapeutics Technical Analysis
Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
03 | 06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |